1.
The Study of Plasm suPAR Level in Malignant Hematologic Diseases;
恶性血液病血浆suPAR水平的临床研究
2.
The Clinical Significance of Hemorheology Examination to Malignant Hematonosis
血液流变学检测对恶性血液病的临床意义
3.
Expression and Significance of PTTG and b-FGF in Acute Leukemia and Multiple Myeloma;
PTTG与b-FGF在恶性血液病中的表达
4.
Methylation of the P～(15)INK4B Gene in Acute Leukemia and Myelodysplastic Syndromes;
恶性血液病中P～（15）基因甲基化的研究
5.
The Significance of GFI1B Expression in Malignant Hematologic Diseases
CFI1B在恶性血液病中的表达及意义
6.
Advances of Research on Demethylation Therapy for Hematologic Malignancies--Review
恶性血液病去甲基化治疗的研究进展
7.
Expression of AnnexinⅡ in Patients with Hematologic Malignancies
恶性血液病患者骨髓AnnexinⅡ基因的表达
8.
Application of SNP-Arrays in Hematological Malignancies--Review
SNP芯片技术在恶性血液病中的应用
9.
Analysis of nosocomial infection in 119 patients with hematological malignant disease
119例恶性血液病患者医院感染分析
10.
Wnt/β-catenin Signal Pathway and Malignant Hematological Disease--Review
Wnt/β-catenin信号通路与恶性血液病
11.
Significance of Marrow Histotomy in Diagnosing Malignant Hemology
骨髓活检在恶性血液病诊断中的意义
12.
Research of Relationship between the Aged Malignant Hematonosis and Kidney Deficiency and Blood Stasis;
老年恶性血液病与肾虚血瘀相关性研究
13.
Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Malignant Hematological Diseases;
造血干细胞移植治疗恶性血液病的研究
14.
Clinical Study of 11 Cases with Hematological Malignant Disease Undergoing Umbilical Cord Blood Transplantation;
同胞脐血移植治疗恶性血液病11例临床研究
15.
The distribution of pancytopenia in malignant hematological disease
恶性血液病全血细胞减少的临床分布特点
16.
Objective: To study the state of erythrocytic immune function in patients with malignant hemopathy.
目的:了解恶性血液病病人红细胞免疫功能状况。
17.
Clinical Study of Invasive Fungal Infections in Hematological Malignancies.;
恶性血液病侵袭性真菌感染的临床研究
18.
Analysis of Diagnosis and Treatment of Invasive Fungal Infections in Patients with Hematologic Malignancy;
恶性血液病合并侵袭性真菌感染的临床分析